GlaxoSmithKline
GlaxoSmithKline officials report on new developments
Published in Healthcare Mergers, Acquisitions and Ventures Week, October 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at GlaxoSmithKline.
Report 1: POZEN Inc. (NASDAQ:POZN) and GlaxoSmithKline (NYSE:GSK) announced that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for Trexima(TM) (sumatriptan/naproxen sodium). An approvable letter is an official notification from the FDA that contains conditions that must be satisfied prior to obtaining final U.S. marketing approval.
In January 2007, POZEN and GSK responded to the FDA's first approvable letter, submitting...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- ActionAid International
HungerFREE Campaign Tells UN: 'Put food on the table' - Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia Drug Pipeline Report Out Now - Addiction Medicine
Alaska Southcentral Foundation Awarded $5 Million in Access to Recovery Grants - Addiction Medicine
Cherokee Nation of Oklahoma Awarded $10.2 Million in Access to Recovery Grants - Addiction Medicine
Inter-Tribal Council of Michigan Awarded $11.7 Million in Access to Recovery Grants - Addiction Medicine
Montana-Wyoming Tribal Leaders Council Awarded $5.7 Million in Access to Recovery Grants - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
